Rational design of a microbial consortium of mucosal sugar utilizers reduces Clostridiodes difficile colonization.
Pereira FC, Wasmund K, Cobankovic I, Jehmlich N, Herbold CW, Lee KS, Lee KS, Sziranyi B, Vesely C, Decker T, Stocker R, Warth B, von Bergen M, Wagner M, Berry D. · 2020
Read Rational design of a microbial consortium of mucosal sugar utilizers reduces Clostridiodes difficile colonization. by Pereira FC, Wasmund K, Cobankovic I, Jehmlich N, Herbold CW, Lee KS, Lee KS, Sziranyi B, Vesely C, Decker T, Stocker R, Warth B, von Bergen M, Wagner M, Berry D. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7547075.txt.
Introduction
Pereira and co-authors design a microbe mix that limits Clostridioides difficile in the gut. This pathogen feeds on sugars from gut mucus. Helpful microbes that use the same sugars can block it.
The team used isotope probing and cell sorting in mouse gut samples. They found which commensals eat mucus sugars in place. Muribaculaceae emerged as major users of those sugars. Other families also took part in smaller roles. A five-member mix was built from sugar users. It cut the pathogen access to key sugars. In treated mice, colonization by the pathogen fell. The work supports targeted design of probiotic mixes.
Catalog record
| CREATOR | Pereira FC, Wasmund K, Cobankovic I, Jehmlich N, Herbold CW, Lee KS, Lee KS, Sziranyi B, Vesely C, Decker T, Stocker R, Warth B, von Bergen M, Wagner M, Berry D. |
|---|---|
| YEAR | 2020 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 99 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Rational design of a microbial consortium of mucosal sugar utilizers reduces Clostridiodes difficile colonization By Fátima C Pereira, Kenneth Wasmund, Iva Cobankovic, Nico Jehmlich, Craig W Herbold, Kang Soo Lee, Barbara Sziranyi, Cornelia Vesely, Thomas Decker, Roman Stocker, Benedikt Warth, Martin von Bergen Published in: Nature Communications DOI: 10.1038/s41467-020-18928-1 ABSTRACT Abstract Many intestinal pathogens, including Clostridioides difficile, use mucus-derived sugars as crucial nutrients in the gut. Commensals that compete with pathogens for such nutrients are therefore ecological gatekeepers in healthy guts, and are attractive candidates for therapeutic interventions. Nevertheless, there is a poor understanding of which commensals use mucin-derived sugars in situ as well as their potential to impede pathogen colonization. Here, we identify mouse gut commensals that utilize mucus-derived monosaccharides within complex communities using single-cell stable isotope probing, Raman-activated cell sorting and mini-metagenomics. Sequencing of cell-sorted fractions reveals members of the underexplored family Muribaculaceae as major mucin monosaccharide foragers, followed by members of Lachnospiraceae, Rikenellaceae, and Bacteroidaceae families. Using this information, we assembled a five-member consortium of sialic acid and N-acetylglucosamine utilizers that impedes C. difficile’s access to these mucosal sugars and impairs pathogen colonization in antibiotic-treated mice. Our findings underscore the value of targeted approaches to identify organisms utilizing key nutrients and to rationally design effective probiotic mixtures. Subject terms: Metagenomics, Microbial ecology, Microbiome, Pathogens INTRODUCTION Host-derived compounds constitute a reliable nutrient source for gut microbes1–3, and can be especially important for sustaining members of the gut microbiota when diet-derived nutrients become scarce4–6. The mucus layer that covers the mammalian intestinal epithelium constitutes a source of carbon and nitrogen for gut bacteria7–10. Highly glycosylated mucins are the dominant structural component of mucus, with O-glycan carbohydrates making up to 80% of the total mucin mass11. Secreted mucin O-glycans have different core structures composed of N-acetylgalactosamine (GalNAc), N-acetylglucosamine (GlcNAc), and galactose residues, which can be further extended with galactose, GlcNAc, GalNAc, fucose or sialic acid (N-acetylneuraminic acid; NeuAc or Neu5Ac) sugar residues, with the latter two frequently occupying terminal positions12–15 (Fig. 1a). The ability of gut bacteria to degrade whole mucin O-glycan structures has been characterized in cultivated gut organisms including representative species from Bacteroides, Bifidobacterium, Akkermansia and Ruminococcus14. Genomic analysis of available human gut bacterial genomes has predicted that 86% of the 397 analyzed organisms possess the capability to cleave, and 89% to catabolize, at least one of the mucin O-glycan monosaccharides14,15. Therefore, the genomic potential to catabolize these compounds is widespread among genomes of gut organisms. However, it is not known which of the organisms harboring the necessary catabolic pathways are key mucosal sugar foragers within the context of natural gut microbial communities, where complex ecological processes may influence the use of different substrates by distinct organisms. Further, it is unclear whether preferences towards particular monosaccharides in O-glycans exist among commensal gut members, as is the case for some pathogens. [Figure: Application of D2O to identify active mucin monosaccharide utilizers.a Experimental setup. Mouse colon contents were diluted in PBS and supplemented with indicated compounds; T0 refers to microcosms processed immediately after establishment. After an incubation period of 6 h, cells from all microcosms were processed as described in the “Methods” section, and subsequently probed for D incorporation by Raman microspectroscopy or sorted based on their incorporated D levels by RACS. Sorted cells were processed for sequencing. b Deuterium incorporation (measured by %CD) of randomly selected cells. Boxes represent median, first and third quartile. Whiskers extend to the highest and lowest values that are within one and a half times the interquartile range. c Average percentage of cells labeled (i.e., with %CD higher than threshold) per microcosm. Bars represent average and standard deviation of independent experiments. The red horizontal line at 2.36 %CD indicates the threshold for considering a cell labeled. It was determined by calculating the mean + 3SD of %CD in randomly selected cells from sample GlucH, in which cells were incubated without addition of heavy water. Different concentrations of compound supplemented to each microcosms are shown below the horizontal axis (c). Asterisk indicates the GlucH sample. Insert chart shows a direct comparison of the percentage of labeled cells in microcosms supplemented with comparable concentrations of each mucosal monosaccharide (5–6 mM) (*p = 0.005; one-way ANOVA). All cells measured from two independent experiments are depicted in (b) and average percentages from both experiments are depicted in (c). d Percentage of supplemented mucosal monosaccharide utilized in three independent microcosms per condition, established with live (gray boxes) or autoclaved (white boxes) biomass. Initial and final (after 6 h) concentrations of compounds were quantified using HILIC for microcosms supplemented with the highest concentration of each compound tested in (c). Boxes represent median, first and third quartile. Whiskers extend to the highest and lowest values that are within one and a half times the interquartile range (*p = 0.0360; **p = 0.0038; ***p = 0.0008 for galactose, NeuAc and fucose, respectively, or ***p = 0.0006 for GalNAc; ns=non-significant; two-tailed Welch two-sample t test). e Initial microcosms composition (family level) determined by 16S rRNA gene amplicon sequencing from three independent experiments (MonoA, B and C). f Variation between samples (Principal Coordinates Analysis based on Bray–Curtis dissimilarities) colored by the monosaccharide supplemented for 3 independent experiments. For each experiment, the initial time point before supplement (T0) and the final time point after incubation (6 h) with each supplemented monosaccharide are represented. The percentage in brackets correspond to the variation explained by each principal coordinate (PCo) to the fraction of the total variance of the data. Source data are provided as a Source Data file.] In addition to commensals, the ability to utilize mucin glycans or particular mucin-derived monosaccharides as a source of nutrients confers a competitive advantage to several gut pathogens16–19. Clostridioides difficile is an important nosocomial pathogen that benefits from host-derived compounds, such as the mucosal sugars NeuAc and GlcNAc, to colonize the gut and cause severe intestinal infections17,19–22. C. difficile is also able to catabolize another mucosal sugar, galactose, though galactose utilization has not been implicated as an important factor for C. difficile colonization19,22. Depletion of the indigenous microbiota by antibiotic treatment is the major risk factor for C. difficile infection (CDI)23,24, and microbiota restoration via fecal microbiota transplantation is currently the most successful way of treating CDI25. Mechanisms through which the indigenous microbiota provides resistance to C. difficile colonization include: (i) production of inhibitory substances such as thuricidin or reuterin26–28, (ii) transformation of bile acids29,30, and (iii) depletion or transformation of host and diet-derived nutrients17,21,31,32. Individual strains or a mixture of four strains that provide partial restoration of colonization resistance to CDI via some of the mechanisms described above have been identified28–30,33. However, no bacteriotherapy mixture able to limit C. difficile use of mucosal sugars has been documented to date. Here we employ deuterium (D) stable isotope probing combined with Raman-activated cell sorting (RACS) and metagenomics to identify organisms that can forage on O-glycan monosaccharides in the mouse gut. This approach allows us to non-destructively track microbial activity at the single-cell level in response to a variety of compounds, thereby enabling post-measurement molecular analysis, and has been successfully employed in the past to identify foragers of host-derived proteins from the mouse gut34,35. Applying this recently developed technique, we identified a